$2.31 +0.08 (%) Aveo Pharmaceuticals Inc - NASDAQ

May. 22, 2015 | 04:00 PM

Partner Headlines

  1. Morning Market Gainers

    Benzinga | May. 22, 2015 | 09:46AM EST
  2. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 22, 2015 | 08:20AM EST
  3. What's Up With The Delayed Reaction In Aveo Pharmaceuticals?

    Benzinga | May. 21, 2015 | 12:01PM EST
  4. Morning Market Gainers

    Benzinga | May. 21, 2015 | 09:49AM EST
  5. Morning Market Gainers

    Benzinga | May. 20, 2015 | 09:43AM EST
  6. AVEO Reports Presentation of Final Results of Extension Study 902, FDA Regulatory Feedback for Advancing Tivozanib in Renal Cell Carcinoma

    Benzinga | May. 20, 2015 | 07:03AM EST
  7. Klarman-Founded Baupost Group Increases Stake In eBay, Trims Micron and Citigroup In Q4

    Benzinga | Feb. 14, 2015 | 19:49PM EST
  8. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

    Benzinga | Jan. 13, 2015 | 11:34AM EST
  9. US Stock Futures Surge Ahead Of ADP Report, Fed Minutes

    Benzinga | Jan. 7, 2015 | 07:06AM EST
  10. US Stock Futures Slightly Higher; Dollar Surges Against Yen

    Benzinga | Nov. 11, 2014 | 07:04AM EST
  11. AVEO Enters into Research And Exclusive Option Agreement With Ophthotech For Tivozanib (VEGF inhibitor) For The Treatment Of Ocular Diseases

    Benzinga | Nov. 11, 2014 | 06:46AM EST
  12. AVEO Oncology Announces Lease Termination And Amendment To Debt Financing Facility

    Benzinga | Sep. 26, 2014 | 07:01AM EST
  13. 3 Biotech Stocks Backed By Big Money

    Benzinga | Jun. 16, 2014 | 14:27PM EST
  14. Morning Market Movers

    Benzinga | Apr. 10, 2014 | 09:42AM EST
  15. Stocks Hitting 52-Week Lows

    Benzinga | Apr. 7, 2014 | 10:35AM EST
  16. Earnings Scheduled For March 13, 2014

    Benzinga | Mar. 13, 2014 | 04:51AM EST
  17. Benzinga Weekly Preview: Ukraine Tension Likely To Drive Markets

    Benzinga | Mar. 7, 2014 | 16:11PM EST
  18. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 16, 2013 | 10:35AM EST
  19. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 13, 2013 | 10:15AM EST
  20. Morning Market Losers

    Benzinga | Dec. 13, 2013 | 10:09AM EST
  21. US Stock Futures Gain Ahead Of Producer Price Index

    Benzinga | Dec. 13, 2013 | 07:07AM EST
  22. AVEO Says Tivozanib Trial in Colorectal Cancer Unlikely to Meet Primary Endpoint

    Benzinga | Dec. 13, 2013 | 06:53AM EST
  23. Wild Card Wonders, Shopping for 52-Week Lows

    GuruFocus | Sep. 28, 2013 | 23:04PM EST
  24. Sure Hope You Ignored This Dude on Aveo Stock

    YCharts | Sep. 16, 2013 | 15:43PM EST
  25. Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low

    GuruFocus | Sep. 3, 2013 | 14:52PM EST
  26. Cutting Loose: Seth Klarman's Active Second Quarter Selling and Trimming

    GuruFocus | Aug. 14, 2013 | 19:51PM EST
  27. 13-F Alert: Baupost Group Adds AIG Shares and Microsoft Call Options

    Benzinga | Feb. 13, 2013 | 11:16AM EST
  28. A Peek Into The Market Before The Trading Starts

    Benzinga | Jan. 29, 2013 | 00:22AM EST
  29. AVEO, Astellas Announce Presentations of Tivozanib Clinical Data

    Benzinga | Jan. 28, 2013 | 23:51PM EST
  30. AVEO Pharmaceuticals Closes Public Offering

    Benzinga | Jan. 23, 2013 | 23:56PM EST
  31. Weekly CEO Buys Highlight: AVEO, ZAZA, TUES, TUES, FRAN, AKVA

    GuruFocus | Dec. 16, 2012 | 05:15AM EST
  32. AVEO Pharmaceuticals, Inc. (AVEO) CEO Ngoc Tuan Ha buys 75,000 Shares

    GuruFocus | Dec. 14, 2012 | 02:37AM EST
  33. A Peek Into The Market Before The Trading Starts

    Benzinga | Nov. 28, 2012 | 00:20AM EST
  34. AVEO, Astellas Announce FDA Acceptance of NDA Filing for Tivozanib

    Benzinga | Nov. 27, 2012 | 23:41PM EST
  35. UPDATE: Stifel Nicolaus Initiates AVEO Pharmaceuticals at Sell; Tivozanib Decision Likely Negative

    Benzinga | Nov. 14, 2012 | 04:22AM EST
  36. UPDATE: Jefferies & Company Reiterates Hold Rating, Lowers PT on Aveo Pharmaceuticals

    Benzinga | Oct. 31, 2012 | 05:30AM EST
  37. AVEO Oncology Announces Strategic Restructuring

    Benzinga | Oct. 30, 2012 | 00:44AM EST
  38. AVEO and Astellas Announce Submission of New Drug Application for Tivozanib

    Benzinga | Sep. 28, 2012 | 01:48AM EST
  39. New Clinical Data on AVEO Oncology's Tivozanib and Ficlatuzumab to be Presented at ESMO 2012 Congress

    Benzinga | Sep. 20, 2012 | 00:39AM EST
  40. Health Care Sector Wrap

    FoxBusiness | Aug. 10, 2012 | 10:50AM EST
  41. Health Care Sector Wrap

    FoxBusiness | Aug. 8, 2012 | 10:46AM EST
  42. NxStage Medical, Assisted Living Concepts Among Stocks setting 52-Week Lows Wednesday

    FoxBusiness | Aug. 8, 2012 | 06:31AM EST
  43. AVEO Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 7, 2012 | 14:28PM EST
  44. Health Care Sector Wrap

    FoxBusiness | Aug. 6, 2012 | 10:44AM EST
  45. ProShares Trust Ultra VIX Short Term Futures ETF, Direxion Daily Large Cap Bear 3X Shares Among Stocks falling to Annual Lows Monday

    FoxBusiness | Aug. 6, 2012 | 06:32AM EST
  46. UPDATE: Jefferies Downgrades Aveo Pharmaceuticals to Hold on Regulatory Risk

    Benzinga | Aug. 3, 2012 | 04:50AM EST
  47. AVEO Pharmaceuticals Inc. (AVEO) CFO David Brannon Johnston sells 15,000 Shares

    GuruFocus | Jun. 8, 2012 | 13:21PM EST
  48. AVEO and Astellas Announce TAURUS Patient Preference Clinical Study Comparing Tivozanib with Sunitinib in First-Line Kidney Cancer

    Benzinga | Jun. 4, 2012 | 01:45AM EST
  49. AVEO Pharmaceuticals Inc. (AVEO) President & CEO Ngoc Tuan Ha sells 4,613 Shares

    GuruFocus | Jan. 30, 2012 | 12:42PM EST
  50. AVEO Pharmaceuticals Inc. (AVEO) CFO David Brannon Johnston sells 1,107 Shares

    GuruFocus | Jan. 30, 2012 | 10:44AM EST
Trading Center